Columbia Labs
This article was originally published in The Tan Sheet
Executive Summary
Approximately 50-65 sales reps to be hired within next six months to detail vaginal pH reducer Miphil, Advantage-S spermicide to OB/GYNS. OTC products will be renamed, repositioned to professional audiences, firm says during analysts' call Aug. 9. Columbia hopes to finalize agreement "with a consumer products company which will assist in marketing these products in the OTC arena" within next few months. Q2 net revenues fell 84% to $427,554, with firm attributing decrease partly to "absence of revenues" from OTC brands sold to Lil' Drugstore Products last year (1"The Tan Sheet" April 24, 2000, In Brief)